Ryan Murphy is a 26-year-old college graduate of California State University, Northridge who lives by the motto, “health is wealth”. He is passionate about health and fitness and enjoys spending time outdoors with friends. However, an unexpected vision challenge threatened Ryan’s healthy and active lifestyle.

After noticing he was struggling to see clearly when driving at night and finding it difficult to see the board during class, Ryan decided to take control of his eye health and made an appointment for an eye exam. During his appointment, Ryan was given a prescription for eyeglasses and sent on his way. Although they did temporarily help his vision, Ryan found the glasses to be cumbersome while working out at the gym. 

In search of a better solution, Ryan returned to the doctor and was shocked when he was diagnosed with progressive keratoconus. He was then referred to Dr. Duna Raoof at NVision in Newport Beach, CA for further evaluation and treatment. During the appointment, Ryan learned about iLink​​® FDA-approved cross-linking, which is proven to slow or halt the progression of keratoconus to help preserve vision. Although Ryan was skeptical at first, he remained positive and did decide to move forward with the procedures. 

We recently connected with Ryan to discuss his experience with progressive keratoconus and how iLink™ has helped him halt the progression of his condition. Now, with the help of scleral lenses[1], Ryan is back to enjoying his workouts and appreciating his health more than ever before. Watch the full video below to learn more! 

For additional information on keratoconus and iLink® FDA-approved cross-linking, or to read more Keratoconus Journeys like Ryan’s, follow Living with KC on Twitter, Instagram, and Facebook.

1. Kreps, E. O., Pesudovs, K., Claerhout, I., & Koppen, C. (2021). Mini-Scleral Lenses Improve Vision-Related Quality of Life in Keratoconus. Cornea, 40(7), 859–864.

Find a Cross-Linking Expert Near You

Search the directory to locate a cross-linking expert who is familiar with treating progressive keratoconus.

The results described on this site are based on data collected regarding short- and intermediate-term efficacy of treatment. Individual results are not guaranteed and may vary.

PM-US-0919 Rev 1